Clinical trial
A Full-Factorial, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Single-Dose Efficacy and Safety Study of an Acetaminophen/Naproxen Sodium Fixed Combination, Acetaminophen, and Naproxen Sodium in Postoperative Dental Pain
NCT05761574 is registered in ClinicalTrials.gov with Johnson & Johnson Consumer Inc. (J&JCI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Full-Factorial, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Single-Dose Efficacy and Safety Study of an Acetaminophen/Naproxen Sodium Fixed Combination, Acetaminophen, and Naproxen Sodium in Postoperative Dental Pain
- Lead sponsor
- Johnson & Johnson Consumer Inc. (J&JCI)
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 22, 2023
- Completion date
- May 30, 2024
- Enrollment
- 447 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.